The Riverside Company Invests in CRIO, Inc.

May 21, 2024

The Riverside Company, via its Riverside Micro-Cap Fund, has made a growth investment in CRIO, Inc., a Boston-based provider of cloud-based eSource, CTMS and regulatory-compliance software for clinical trial sites, CROs and pharmaceutical/biotech sponsors. Riverside’s capital will support accelerated product development, broader product offerings and potential strategic acquisitions as CRIO scales.

Buyers
The Riverside Company (Riverside Micro-Cap Fund)
Targets
CRIO, Inc.
Industry
Cloud & SaaS
Location
Massachusetts, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.